Is it time to leave the avoidance of rupture of membranes for women infected with HIV and receiving cART in the past?

BJOG. 2016 May;123(6):982. doi: 10.1111/1471-0528.13445. Epub 2015 May 22.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active*
  • Female
  • HIV Infections / drug therapy
  • HIV-1
  • Humans
  • Viral Load

Substances

  • Anti-HIV Agents